Dermatologic drugs should be employed with caution in women of childbearing age who are pregnant or considering pregnancy. Topical drugs have little systemic absorption. Therefore, they are deemed safer than oral or parenteral agents and less likely to harm the fetus. However, their safety profile must be assessed cautiously, as there is limited available data. In this article, we aggregate human and animal studies and provide recommendations on using topical dermatologic medications in pregnancy.
|Original language||English (US)|
|Number of pages||5|
|Journal||Journal of Drugs in Dermatology|
|State||Published - Jul 2016|
All Science Journal Classification (ASJC) codes